Insulet
PODD
203 hedge funds and large institutions have $4.34B invested in Insulet in 2017 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 72 increasing their positions, 58 reducing their positions, and 15 closing their positions.
193% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 15
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
25% more capital invested
Capital invested by funds: $3.46B → $4.34B (+$879M)
24% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 58
17% more funds holding
Funds holding: 174 → 203 (+29)
14% more call options, than puts
Call options by funds: $3.19M | Put options by funds: $2.81M
0.11% less ownership
Funds ownership: 108.19% → 108.08% (-0.11%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$41M |
| 2 |
Millennium Management
New York
|
+$37.5M |
| 3 |
Renaissance Technologies
New York
|
+$33.3M |
| 4 |
FAM
Fred Alger Management
New York
|
+$29.1M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$24.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SPC
Slate Path Capital
New York
|
-$141M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$112M |
| 3 |
VM
Valinor Management
New York
|
-$67.8M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$23M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
-$21.5M |
PODD Hedge Fund Activity: Q4 2017 in Review
203 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q4 2017, worth a combined $4.34B — up 25% from $3.46B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new PODD positions and 15 closed out — a net gain of 29 holders — while 72 added to existing stakes and 58 trimmed.
The largest buyer was Frontier Capital Management, adding an estimated $41M. The largest seller was Slate Path Capital, cutting an estimated $141M.
- 203 institutional investors held Insulet (PODD) as of Q4 2017, up from 174 in Q3 2017.
- Funds reported $4.34B of Insulet stock for Q4 2017, up 25% quarter-over-quarter.
- 44 funds opened new Insulet positions in Q4 2017 and 15 closed out, a net change of +29 holders.
- The largest Insulet buyer in Q4 2017 was Frontier Capital Management, an estimated $41M added.
- The largest Insulet seller in Q4 2017 was Slate Path Capital, an estimated $141M sold.
Based on aggregated 13F filings for Q4 2017.